新闻稿

Illumina to Announce Third Quarter 2017 Financial Results on Tuesday, October 24, 2017

SAN DIEGO--(BUSINESS WIRE)--Oct. 10, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2017 following the close of market on Tuesday, October 24, 2017.

On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Senior Vice President and Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Tuesday, October 24, 2017. Interested parties may access the live teleconference through the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. Alternatively, individuals can access the call by dialing 888-771-4371, or 1-847-585-4405 outside North America, both with passcode 45640029.

A replay of the conference call will be available from 4:30 pm Pacific Time (7:30 pm Eastern Time) on October 24, 2017 through October 31, 2017 by dialing 888-843-7419, or 1-630-652-3042 outside North America, both with passcode 45640029.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Jacquie Ross, CFA, 858-882-2172
ir@illumina.com
or
Media:
Eric Endicott, 858-882-6822
pr@illumina.com

Recent Articles

在全新MiSeq™ i100系列中实现可持续的测序
在全新MiSeq™ i100系列中实现可持续的测序
对所有血癌进行全基因组测序的案例越来越多
对所有血癌进行全基因组测序的案例越来越多
独立检测证明DRAGEN提供了更为全面的基因组信息
独立检测证明DRAGEN提供了更为全面的基因组信息